ADPT (STOCKS)
Adaptive Biotechnologies Corporation Common Stock
$17.805000
+0.205000 (+1.16%)
Prev close: $17.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Chad Robins
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,849.59M
- Employees
- 619
- P/E (TTM)
- -53.76
- P/B (TTM)
- 12.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.12 | $-0.16 | +0.0432 | +26.47% |
|
Dec 2025 (Q4)
|
$-0.09 | $-0.18 | +0.0949 | +51.33% |
|
Sep 2025 (Q3)
|
$0.06 | $-0.15 | +0.2092 | +140.21% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.24 | +0.0735 | +30.18% |
Financial Statements
| Revenues | $295.41M |
| Benefits Costs and Expenses | $345.05M |
| Cost Of Revenue | $73.09M |
| Costs And Expenses | $342.13M |
| Gross Profit | $222.32M |
| Operating Expenses | $269.04M |
| Depreciation and Amortization | $15.08M |
| Research and Development | $93.19M |
| Other Operating Expenses | $160.77M |
| Operating Income/Loss | -$46.73M |
| Income/Loss From Continuing Operations After Tax | -$49.64M |
| Income/Loss From Continuing Operations Before Tax | -$49.64M |
| Interest Expense, Operating | $11.76M |
| Net Income/Loss | -$49.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $38.00K |
| Net Income/Loss Attributable To Parent | -$49.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$49.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.33 |
| Diluted Earnings Per Share | -$0.33 |
| Basic Average Shares | 460,509,180 |
| Diluted Average Shares | 471,238,980 |
| Assets | $505.94M |
| Current Assets | $291.81M |
| Inventory | $11.21M |
| Other Current Assets | $280.60M |
| Noncurrent Assets | $214.14M |
| Fixed Assets | $30.77M |
| Other Non-current Assets | $183.36M |
| Liabilities | $281.70M |
| Current Liabilities | $87.01M |
| Accounts Payable | $9.62M |
| Wages | $6.22M |
| Other Current Liabilities | $71.18M |
| Noncurrent Liabilities | $194.69M |
| Equity | $224.24M |
| Equity Attributable To Noncontrolling Interest | $7.90M |
| Equity Attributable To Parent | $216.34M |
| Liabilities And Equity | $505.94M |
| Net Cash Flow From Operating Activities | -$27.04M |
| Net Cash Flow From Operating Activities, Continuing | -$27.04M |
| Net Cash Flow From Investing Activities | $21.52M |
| Net Cash Flow From Investing Activities, Continuing | $21.52M |
| Net Cash Flow From Financing Activities | $32.45M |
| Net Cash Flow From Financing Activities, Continuing | $32.45M |
| Net Cash Flow | $26.93M |
| Net Cash Flow, Continuing | $26.93M |
| Comprehensive Income/Loss | -$49.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $38.00K |
| Comprehensive Income/Loss Attributable To Parent | -$49.84M |
| Other Comprehensive Income/Loss | -$162.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$162.00K |